01.27.26 -- Navigating FDA's New AI Systems

Real-time eCOA data enables faster eligibility decisions, proactive issue alerts, and streamlined operations by unifying data, improving precision, responsiveness, and trial execution efficiency.

I-SPY 2, one of the longest-running adaptive platform trials in oncology, is revolutionizing breast cancer research through a dynamic, data-driven approach to evaluating novel therapies.

Digital biomarkers enable continuous and objective data collection, significantly reducing the variability and subjectivity inherent in traditional assessments.

Central eSource transforms the conduct of clinical trials by replacing disparate, site-specific source templates with a unified, sponsor-designed framework.

Unlock seamless software development with IQVIA’s eCOA, which automates screenshots, validation documentation, and audit trails, ensuring real-time updates, easy exports, and full traceability.